Invitrogen™ Human CD264 (TRAIL-R4) Synthetic Peptide

Catalog No.	Quantity
PEP0022	50 μg

Catalog No. PEP0022 Supplier Invitrogen™ Supplier No. PEP0022

Description

Synthetic Peptide

DcR2 Synthetic Peptide, PEP-0022, from Invitrogen.

TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. A fourth member of the emerging TRAIL receptor family, TRAIL-R4, has signaling capacity similar to that of TRAIL-R1 and TRAIL-R2 with respect to NF-kappaB activation, but differs in its inability to induce apoptosis. Like TRAIL-R1 and TRAIL-R2, this receptor shows widespread tissue expression. The human TRAIL-R4 gene has been mapped to chromosome 8p22-21, clustered with three other TRAIL receptors.

Specifications

• Gene ID (Entrez): 8793
• Species: Human
• Purification Method: purified
• Accession Number: Q9UBN6
• Common Name: Human CD264 (TRAIL-R4)
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: TNFRSF10D
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS